Research And Education

At Stony Brook Medicine, research and education are key components of our mission. Our child neurology physicians are members of the faculty of the Stony Brook University School of Medicine, and teach medical students, residents and fellows on an ongoing basis. Multiple studies of anti-epileptic drugs and vagal nerve stimulation have been conducted over the years, and the staff presents and publishes their work extensively. Dr. Mary Andriola co-authored a volume on EEG that has been widely used in medical training. She has led or been a participating physician in dozens of clinical trials, and has authored and co-authored dozens of scientific papers and abstracts. Dr. Andriola is Principal Investigator for two upcoming multicenter randomized double-blind, placebo-controlled trials to assess the safety and efficacy of pharmaceutical cannabidiol oral solution as an adjunctive therapy for treatment of subjects with inadequately controlled Lennox-Gastaut or Dravet syndromes. As a New York State-licensed medical doctor for medical marijuana, Dr. Andriola is currently treating patients with epilepsy requesting cannabidiol therapy and beginning a study of these patients.

Dr. Jill Miller-Horn is a peer reviewer for Clinical Pediatrics. 

Recent publications by faculty include:

Miller-Horn JW, Andriola MR, Coyle PK, Gerber O, Melvin JJ. Determination of Death By Neurological Criteria: What Do We Know and When Did We Learn It? [Abstract.] Annals of Neurology, 66 (Suppl 13), 135, October 2009

Miller-Horn J, Spiegel R, Bello L, and Andriola MR. Clinical Experience with Rufinamide in an Academic Medical Center. Epilepsia 50 Suppl. 2009. 

Dzhafarova N, Bindra T, Andriola MR and Spiegel R. Neurodevelopmental Outcome in Children Exposed to Antiepileptic Drugs in Utero. Epilepsia 50 Suppl. 2009.

Venkatraman G, Shmerkovich D, Andriola MR, Zilberman I and Spiegel R. Prevalence of Status Epilepticus in the Critical Care Patient Population. Epilepsia 50 Suppl. 2009.

Patel, P, Andriola M, Spiegel R: Paradoxical Seizures During Treatment with Rufinamide. Epilpsia v3 Suppl. 2012.